Medical Biosafety News
-
CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has recently launched its new line of PLGA-based drug delivery systems for in vitro and in vivo applications, including biocompatible and biodegradable PLGA nanoparticles with different surface modifications (e.g., COOH groups, methoxy PEG, and PEG-azide). In recent years, the development of nanotechnology ...
-
Common problems and countermeasures in the production of medical sterilized paper plastic packaging bags
The medical sterilization paper plastic packaging bag is a disposable medical sterilization packaging material, which has the advantages of good air permeability, good penetration of sterilization medium, high bacteria resistance after sterilization, convenient chemical monitoring during sterilization, simple package sealing, good perspective, long safety period after sterilization, easy opening, ...
-
Exclusive License Agreement With Case Western Reserve University for Core-NK Platform (Supplementary Announcement)
Further to the announcement of the exclusive option to license the CORE-NK platform released on 21 November 2022, at the request of the ASX, Chimeric Therapeutics (ASX: CHM, “Chimeric”), a clinical-stage cell therapy company and an Australian leader in cell therapy, provides additional information regarding an exclusive license agreement with Case Western Reserve University (CWRU) for ...
-
Exclusive License Agreement With Case Western Reserve University for Core-NK Platform
Exclusive global license for CORE NK platform (CHM 0201) executed with Case Western Reserve University in Ohio Initial Phase 1 clinical trial results of the CORE NK platform (CHM 0201) were published demonstrating safety and encouraging activity in blood cancers and solid tumours One patient achieved a complete response that was sustained for over 15 months at time of publication Based on ...
-
Creative Proteomics Lipidomics Platform Boosts Short Chain Fatty Acids Research
Lipidomics, a platform developed by Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, and biotechnological and pharmaceutical companies. The Lipidomics platform now employs gas chromatography-mass spectrometry (GC-MS) methods to enable fast and accurate qualitative and quantitative analysis of a ...
-
SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ Tumors
WATERTOWN, Mass.--(BUSINESS WIRE)-- SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for the company’s lead cell therapy candidate, SQZ-PBMC-HPV, for the treatment of HPV16+ advanced or metastatic solid tumors. Fast ...
-
STEMart Launches Pyrogenicity Testing Service for Medical Devices
STEMart, a provider of integrated medical device CRO services dedicated to medical device and diagnostic clinical development, now launches Pyrogenicity Testing service for the medical device industry. This new testing follows the biocompatibility guidelines modified for medical devices. Due to the risks associated with medical devices, comprehensive medical device testing throughout the product ...
By STEMart
-
Amerigo Scientific Launches 2',3'-Diacetyl Guanosine (n-ibu)
Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science research communities, now introduces 2′,3′-Diacetyl Guanosine (n-ibu) for life science applications. This 2′,3′-Diacetyl Guanosine (n-ibu) is an addition of Amerigo Scientific’s portfolio of Mononucleotides and Nucleosides. Nucleosides are ...
-
Amerigo Scientific Introduces the Launch of Polystreptavidin 350
Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science research communities, now introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA. Diagnosis is a key enabler of universal health coverage and the first line of defense against the spread of many diseases. From rapid treatment and combating ...
-
Agreement signed with TELA Bio Inc
Next Science Limited (ASX:NXS) (Next Science) is pleased to announce that it has signed a multi-year distribution agreement with NASDAQ listed medical technology company, TELA Bio, Inc in relation to the supply of a white labelled version of Next Science’s proprietary XPERIENCETM No Rinse Antimicrobial Solution. The new agreement grants TELA Bio, Inc exclusive rights across the US plastic ...
-
Biorez Announces FDA 510(k) Clearance of Its Proprietary BioBrace Implant Technology
Biorez Inc., a New Haven start-up advancing tendon and ligament healing, announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for two sizes of its BioBrace Implant. This new biocomposite soft tissue scaffold is intended to be used in a broad range of surgical procedures to reinforce soft tissue where weakness exists, and can be used with ...
By Biorez Inc.
-
CELLINK and Atelerix team up to enable the shipping at room temperature of fragile 3D bioprinted constructs by the world’s bioprinting community
CELLINK and Atelerix announced today a partnership to bring to market Atelerix’s portfolio of innovative hydrogel biological encapsulation products, which preserve fragile biological samples for shipping at room temperature. Conventional shipping methods often involve storing cells and tissues in liquid nitrogen or dry ice, which requires a freeze-thaw process notorious for ...
By Atelerix Ltd
-
Endomedix publishes ground breaking research and method development for the use of biologically derived polysaccharides in implantable medical devices in peer reviewed journal
Endomedix, Inc. announced today the first of a series of publications of its research and patented technology for a new family of biomaterials based on natural polysaccharides. Appearing in the Journal of Applied Polymer Science, the article, “Reproducible, biocompatible medical materials from biologically derived polysaccharides: Processing and Characterization”, addresses the ...
-
A2LA Accredits Cornell Veterinary Biobank to New ISO 20387 International Standard
A2LA is proud to announce the issuance of its first accreditation, and the first such accreditation in the world, to the newly published standard ISO 20387:2018 – Biobanking – General requirements for biobanking. ISO 20387 contains requirements designed to demonstrate the competence of a biobank’s operation and ability to provide biological material and associated data for ...
-
VIVAX BIO and 3D Bioprinting Solutions World’s First To Print Living Tissue in Space
VIVAX BIO, 3D Bioprinting Solutions biotechnology laboratory and INVITRO, a leading medical company, announced a successful completion of the first stage of the Magnetic 3D Bioprinter space experiment. On December 3, 2018, the Organ.Aut bioprinter was delivered to the ISS on board the Soyuz MS-11 manned spacecraft. For the first time on orbit, cosmonaut-researcher Oleg Kononenko printed human ...
-
Establishing interdisciplinary approaches to agriculture and fundamental biological processes
Original story at MIT News From optimizing food production to feed a growing population to discovering the fundamental behaviors and processes of biopolymers, faculty in the Department of Civil and Environmental Engineering (CEE) are leveraging the interdisciplinary nature of the department to establish two new, innovative projects. H.M. King Bhumibol Professor Dennis McLaughlin, a hydrologist, ...
-
EnviroChemie wins order for wastewater deactivation and detoxification from major vaccine producer
The wastewater from vaccine production at a world-leading pharmaceutical company will be safely deactivated and processed before being released into the sewer system. Plant constructor EnviroChemie has won the order for the planning, construction and commissioning of two wastewater processing plants for the production wastewater from a Benelux pharmaceutical company. The expansion of the ...
-
ASTM F1855 - 00(2011) Standard Specification for Polyoxymethylene (Acetal) for Medical Applications
This specification covers polyoxymethylene (acetal) resin for medical applications. This specification provides requirements and associated test methods for a form of this thermoplastic which is intended for use in manufacturing medical devices, instrumentation or components thereof. Physical and mechanical properties of medical grade ...
-
Formaldehyde in the hospital environment
Formaldehyde is found in the hospital environment at higher concentrations than those to which the general population is exposed. It's possible adverse health effects are therefore very important to those working in certain parts of hospitals and to patients whose health status may be compromised. The compound is an irritant and can cause sensitisation Formaldehyde is a colourless gas with a ...
-
EU allergy and asthma network marks its achievements
The Global Allergy and Asthma European Network (GA2LEN)1, established in 2005 to facilitate excellence in allergy research across clinical and research institutions in Europe, has recently published a report on its major achievements. Funded by the EU, GA2LEN is composed of a multidisciplinary research network centred on scientific projects in allergy and asthma. It integrates research on ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you